Reply letter to: Signet ring cell carcinoma as a potential confounding factor in the analysis of outcomes with colorectal mucinous adenocarcinoma

European Journal of Cancer

Volumn 48, Issue 16, 2012, Pages 3128-3129

  Mekenkamp, L J M ^a   Heesterbeek, C J ^a   Punt, C J A ^b   Nagtegaal, I D ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; IRINOTECAN; MUCIN; OXALIPLATIN;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL TRIAL (TOPIC); COLORECTAL CARCINOMA; COLORECTAL MUCINOUS ADENOCARCINOMA; HISTOPATHOLOGY; HUMAN; LETTER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SIGNET RING CARCINOMA;

EID: 84867571795     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.08.014     Document Type: Letter

References (5)

1. Mekenkamp LJM, Heesterbeek K, Koopman M, et al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer 2012;48:501-9.
2. Kang H, O'Connell JB, Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 2005;48:1161-8.
3. Borger ME, Gosens MJEM, Jeuken JWM, et al. Signet ring cell Differentiation in mucinous colorectal carcinoma. J Pathol 2007; 212:278-86.
4. Pande R, Sunga AMPH, LeVea C, et al. Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum 2007; 51:50-1.
5. Sung CO, Seo JW, Kim K, et al. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Mod Pathol 2008; 21:1533-41.